Vivos Therapeutics Expands Management Team
Vivos Therapeutics, Inc. (NASDAQ: VVOS) is proud to announce exciting new leadership changes aimed at driving growth and innovation in the treatment of obstructive sleep apnea (OSA). The company has recently appointed Michael (Mike) E. Bruhn as the Executive Vice President of Business Operations Integration and Dr. Terry Jones as the Senior Vice President of Human Resources.
Commitment to Excellence
These strategic appointments highlight Vivos' dedication to enhancing its new sleep testing center and direct patient treatment operations. This growth initiative is underscored by Vivos' acquisition of The Sleep Center of Nevada and ongoing explorations for similar acquisitions or collaborations aimed at revenue enhancement.
New Leadership Profiles
Mr. Bruhn and Dr. Jones share a profound commitment to the mission of Vivos—eliminating OSA, a common yet underdiagnosed health issue. Under the guidance of R. Kirk Huntsman, Chairman and CEO, both leaders are set to play pivotal roles in the company's transformation.
Strategic Focus of Michael Bruhn
In his new position, Mr. Bruhn will focus on expanding Vivos' reach, particularly in the Eastern United States. His responsibilities include managing the integration of existing and future acquisitions into Vivos' business framework. He aims to foster scalable growth and enhance efficiency, improving access to Vivos' innovative devices for patients battling OSA.
Collaboration with Existing Leaders
Working closely with Susan McCullough, the Executive Vice President of Operations and Co-Founder of Vivos, Mr. Bruhn will oversee all facets of the practical implementation of Vivos' range of OSA treatments in collaboration with dentists and medical professionals.
Impressive Background of Dr. Terry Jones
Dr. Jones brings over two decades of leadership experience from diverse sectors, including federal agencies and international nonprofits. His previous role as Vice President of Human Resources at the USIP showcased his strategic vision and commitment to people-first leadership.
Transformative Human Resource Strategies
As a seasoned HR executive and U.S. Air Force veteran, Dr. Jones is skilled in driving transformative human resources strategies across large organizations. He has previously supported military and civilian personnel in demanding environments, enhancing organizational culture and talent management frameworks along the way.
An Exciting Journey Ahead for Vivos
Mr. Bruhn expressed enthusiasm for joining Vivos at a pivotal moment: "I am excited to leverage my operational expertise in healthcare to support Vivos' growth strategy. My priority will be ensuring that acquisitions, like the Sleep Center of Nevada, are integrated seamlessly into the Vivos ecosystem. This approach will enable us to maximize revenue growth potential as we evolve our strategies."
Further, Dr. Jones articulated his eagerness to shape the company's human resources function by fostering a thriving workplace culture: "It's an honor to be part of Vivos during such significant growth. Collaborating with colleagues to build a supportive environment where every voice is heard is truly inspiring. My goal is to create a workplace that not only values contributions but also enhances employee engagement and satisfaction."
Company Overview
Founded in 2016, Vivos Therapeutics, Inc. is a pioneering medical technology company dedicated to revolutionizing treatment methods for patients suffering from breathing and sleep challenges, especially obstructive sleep apnea (OSA). The company's innovative Complete Airway Repositioning and/or Expansion (CARE) devices are notably the first oral appliances cleared by the U.S. FDA for treating patients with all severity levels of OSA, including severe cases.
Addressing OSA on a Global Scale
With OSA affecting over 1 billion people globally and a staggering 90% unaware of their condition, Vivos is stepping up to tackle this public health crisis. By focusing on sustainable, noninvasive, and innovative solutions, the company aims to empower healthcare providers to better manage the complexities surrounding OSA.
Looking Ahead
With its cutting-edge, nonsurgical oral appliances, Vivos Therapeutics is enabling thousands of patients to regain control over their health and well-being. The continuous development and expansion within this field are just the beginning, and Vivos is set to lead the industry with innovative treatment solutions that matter.
Frequently Asked Questions
What is the primary goal of Vivos Therapeutics?
The primary goal of Vivos Therapeutics is to eliminate obstructive sleep apnea (OSA) through innovative treatment solutions and expanded patient access.
Who is Michael Bruhn?
Michael Bruhn has been appointed as the Executive Vice President of Business Operations Integration at Vivos, focusing on operational growth and integration of acquisitions.
What distinguishes Vivos' CARE devices?
Vivos' Complete Airway Repositioning and/or Expansion (CARE) devices are FDA-cleared for all severity levels of OSA, offering a unique approach to treatment.
How is Dr. Terry Jones contributing to Vivos?
Dr. Terry Jones serves as the Senior Vice President of Human Resources, focusing on building a positive workplace culture and enhancing human resources strategies.
What is Vivos' mission?
The mission of Vivos is to address obstructive sleep apnea effectively, providing innovative solutions that empower both patients and healthcare providers.
